PRESS RELEASES

April 11, 2019 in Press Releases

Avails Medical announcing eQuant, a novel IVD being developed to allow rapid standardized inoculum generation directly from a positive blood culture

Product integrates to non-rapid commercial AST, antibiotic susceptibility test, systems and dramatically shortens the process. Menlo Park, Calif., Apr. 11th, 2019 (PRESS RELEASE) -- Avails Medical, Inc. (www.availsmedical.com), an in-vitro... Read More

EVENTS

ASM Conference, San Francisco, CA June 20-24 2019

Avails Medical, Inc. will showcase its eQuant technology at the annual ASM conference 2019 in San Francisco. Visit us at booth #844

eQuant is bridging the gap between rapid identification (ID) methods and legacy AST systems by providing a standardized inoculum (McFarland) directly from a positive blood culture in as fast as 1 hour.

MEDIA

Recent Posts / View All Posts

Avails has been featured on German TV

| Media | No Comments
Hightech oder Hoelle Leben im Silicon Valley Avails has been featured on German TV (VOX) documentary about the Silicon Valley